Initial public offerings scheduled to debut next week

NEW YORK, N.Y. – The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.

Week of July 25:

Bioventus – Durham, N.C., 8.8 million shares, priced $16-$18, managed by J.P. Morgan/Piper Jaffray. Proposed Nasdaq symbol BIOV. Business: Offers non-invasive and surgical products for musculoskeletal conditions.

Kadmon Holdings – New York, 5.6 million shares, priced $16-$20, managed by Citi/Jefferies. Proposed NYSE symbol KDMN. Business: Developing kinase inhibitors for autoimmune disease, fibrosis and solid tumors.

Kinsale Insurance – Richmond, Va., 6 million shares, priced $14-$16, managed by J.P. Morgan/William Blair/RBC Capital Markets. Proposed Nasdaq symbol KNSL. Business: Multi-line insurer providing excess and surplus insurance.

Talend – Redwood City, Calif., 5.25 million shares, priced $15-$17, managed by Goldman sachs/J.P. Morgan/Barclays. Proposed Nasdaq symbol TLND. Business: Provides an open source data integration platform to enterprise customers.